Literature DB >> 33706408

Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer.

Frederik Wessels1,2, Max Schmitt1, Eva Krieghoff-Henning1, Tanja Jutzi1, Thomas S Worst2, Frank Waldbillig2, Manuel Neuberger2, Roman C Maron1, Matthias Steeg3, Timo Gaiser3, Achim Hekler1, Jochen S Utikal4,5, Christof von Kalle6, Stefan Fröhling7, Maurice S Michel2, Philipp Nuhn2, Titus J Brinker1.   

Abstract

OBJECTIVE: To develop a new digital biomarker based on the analysis of primary tumour tissue by a convolutional neural network (CNN) to predict lymph node metastasis (LNM) in a cohort matched for already established risk factors. PATIENTS AND METHODS: Haematoxylin and eosin (H&E) stained primary tumour slides from 218 patients (102 N+; 116 N0), matched for Gleason score, tumour size, venous invasion, perineural invasion and age, who underwent radical prostatectomy were selected to train a CNN and evaluate its ability to predict LN status.
RESULTS: With 10 models trained with the same data, a mean area under the receiver operating characteristic curve (AUROC) of 0.68 (95% confidence interval [CI] 0.678-0.682) and a mean balanced accuracy of 61.37% (95% CI 60.05-62.69%) was achieved. The mean sensitivity and specificity was 53.09% (95% CI 49.77-56.41%) and 69.65% (95% CI 68.21-71.1%), respectively. These results were confirmed via cross-validation. The probability score for LNM prediction was significantly higher on image sections from N+ samples (mean [SD] N+ probability score 0.58 [0.17] vs 0.47 [0.15] N0 probability score, P = 0.002). In multivariable analysis, the probability score of the CNN (odds ratio [OR] 1.04 per percentage probability, 95% CI 1.02-1.08; P = 0.04) and lymphovascular invasion (OR 11.73, 95% CI 3.96-35.7; P < 0.001) proved to be independent predictors for LNM.
CONCLUSION: In our present study, CNN-based image analyses showed promising results as a potential novel low-cost method to extract relevant prognostic information directly from H&E histology to predict the LN status of patients with prostate cancer. Our ubiquitously available technique might contribute to an improved LN status prediction.
© 2021 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International.

Entities:  

Keywords:  #PCSM; #ProstateCancer; #uroonc; artificial intelligence; convolutional neural network; deep learning; machine learning; neoplasm metastasis; prostatic neoplasms

Mesh:

Year:  2021        PMID: 33706408     DOI: 10.1111/bju.15386

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  10 in total

1.  Prediction Performance of Deep Learning for Colon Cancer Survival Prediction on SEER Data.

Authors:  Surbhi Gupta; S Kalaivani; Archana Rajasundaram; Gaurav Kumar Ameta; Ahmed Kareem Oleiwi; Betty Nokobi Dugbakie
Journal:  Biomed Res Int       Date:  2022-06-16       Impact factor: 3.246

2.  Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer.

Authors:  Ziwei Wei; Dunsheng Han; Cong Zhang; Shiyu Wang; Jinke Liu; Fan Chao; Zhenyu Song; Gang Chen
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

3.  Identification of metastatic primary cutaneous squamous cell carcinoma utilizing artificial intelligence analysis of whole slide images.

Authors:  Jaakko S Knuutila; Pilvi Riihilä; Antti Karlsson; Mikko Tukiainen; Lauri Talve; Liisa Nissinen; Veli-Matti Kähäri
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

Review 4.  Patients with Positive Lymph Nodes after Radical Prostatectomy and Pelvic Lymphadenectomy-Do We Know the Proper Way of Management?

Authors:  Bartosz Małkiewicz; Miłosz Knura; Małgorzata Łątkowska; Maximilian Kobylański; Krystian Nagi; Dawid Janczak; Joanna Chorbińska; Wojciech Krajewski; Jakub Karwacki; Tomasz Szydełko
Journal:  Cancers (Basel)       Date:  2022-05-08       Impact factor: 6.575

5.  The dawning of the age of artificial intelligence in urology.

Authors:  Louise Stone
Journal:  Nat Rev Urol       Date:  2021-06       Impact factor: 14.432

6.  Potential of Internet of Medical Things (IoMT) applications in building a smart healthcare system: A systematic review.

Authors:  Ruby Dwivedi; Divya Mehrotra; Shaleen Chandra
Journal:  J Oral Biol Craniofac Res       Date:  2021-12-11

7.  Identifying the Candidates Who Will Benefit From Extended Pelvic Lymph Node Dissection at Radical Prostatectomy Among Patients With Prostate Cancer.

Authors:  Guanjie Yang; Jun Xie; Yadong Guo; Jing Yuan; Ruiliang Wang; Changcheng Guo; Bo Peng; Xudong Yao; Bin Yang
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

8.  Deep learning for evaluation of microvascular invasion in hepatocellular carcinoma from tumor areas of histology images.

Authors:  Qiaofeng Chen; Han Xiao; Yunquan Gu; Zongpeng Weng; Lihong Wei; Bin Li; Bing Liao; Jiali Li; Jie Lin; Mengying Hei; Sui Peng; Wei Wang; Ming Kuang; Shuling Chen
Journal:  Hepatol Int       Date:  2022-03-28       Impact factor: 9.029

Review 9.  Artificial intelligence for renal cancer: From imaging to histology and beyond.

Authors:  Karl-Friedrich Kowalewski; Luisa Egen; Chanel E Fischetti; Stefano Puliatti; Gomez Rivas Juan; Mark Taratkin; Rivero Belenchon Ines; Marie Angela Sidoti Abate; Julia Mühlbauer; Frederik Wessels; Enrico Checcucci; Giovanni Cacciamani
Journal:  Asian J Urol       Date:  2022-06-18

10.  Deep learning techniques for cancer classification using microarray gene expression data.

Authors:  Surbhi Gupta; Manoj K Gupta; Mohammad Shabaz; Ashutosh Sharma
Journal:  Front Physiol       Date:  2022-09-30       Impact factor: 4.755

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.